# Shivalik Rasayan share price today (Shivalik Rasayan Ltd, NSE: SHIVALIK) > Shivalik Rasayan share price today: ₹291.20 at the NSE close on 18 November 2026, down 28.1% in a year. Shivalik Rasayan (NSE: SHIVALIK) is worth ₹467 crore, trades at a P/E of 32.2 and has closed between ₹212.90 and ₹414.85 over the past 52 weeks. > Shivalik Rasayan Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 32% of past readings. SHIVALIK · Pesticides/Agrochemicals · data as of 18 November 2026. Page: https://www.sectoralpha.in/stocks/shivalik-rasayan-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Business trend: Mixed, from fewer quarters than usual - Price: ₹291.20 (−28.1% in a year) - P/E: 32.2× (lower than 68% of the last 11 years) - Revenue (Sep 2026): ₹101 Cr (+7.2% on a year ago) - Profit (Sep 2026): ₹5.4 Cr (+25.3% on a year ago) - Operating margin: 14.7% (+1.9 points on a year ago) - ROCE: 5%, FY26 - Profit that came in as cash: −88%, last 3 years The main question: profits are rising, but only −88% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Shivalik Rasayan share price today? Shivalik Rasayan Ltd's share price was ₹291.20 at the close on 18 November 2026. It is in an uptrend that has just slipped below its 200-day average. That is 9.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹213 and ₹415, and at that close it sat 39% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running. Over the last 11 years the share price moved +860% while the NIFTY 500 moved +268%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 8 November 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What are Shivalik Rasayan's latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Shivalik Rasayan reported revenue of ₹101 crore, up 7.2% from ₹93.8 crore a year earlier, and a profit of ₹5.40 crore, up 25.3% from ₹4.31 crore. ### Shivalik Rasayan results: July to September 2026 against a year earlier | Measure | July to September 2026 | July to September 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹101 crore | ₹93.8 crore | +7.2% | | Profit | ₹5.40 crore | ₹4.31 crore | +25.3% | | Earnings per share | ₹2.30 | ₹1.94 | +18.6% | | Operating margin | 14.7% | 12.8% | +1.9 points | The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.) ## What is the Shivalik Rasayan share price history? Shivalik Rasayan closed at ₹291.20 on 18 November 2026, down 28.1% from ₹405.05 a year earlier (21 November 2025) and down 67.2% over five years. Its highest weekly close since April 2016 was ₹1,125.45 on 7 January 2022. ### Shivalik Rasayan share price: then and now | When | Close | Change to 18 Nov 2026 | | --- | --- | --- | | 1 week ago · 11 Nov 2026 | ₹305.75 | −4.8% | | 1 month ago · 19 Oct 2026 | ₹326.30 | −10.8% | | 1 year ago · 21 Nov 2025 | ₹405.05 | −28.1% | | 3 years ago · 17 Nov 2023 | ₹656.75 | −55.7% | | 5 years ago · 18 Nov 2021 | ₹886.85 | −67.2% | | 10 years ago · 18 Nov 2016 | ₹92.52 | +214.7% | | Earliest and lowest weekly close in our records · 1 Apr 2016 | ₹30.34 | +859.8% | | Highest weekly close since April 2016 · 7 Jan 2022 | ₹1,125.45 | −74.1% | | 52-week high (weekly close) · 28 Sep 2026 | ₹414.85 | −29.8% | | 52-week low (weekly close) · 25 Jun 2026 | ₹212.90 | +36.8% | Weekly closing prices. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (539 weekly closes from 1 April 2016 to 18 November 2026.) ## What is the latest news on Shivalik Rasayan? 18 Nov 2026: Shivalik Rasayan closed at ₹291.20, down 4.8% on the week and down 10.8% on the month. Results for July to September 2026: Revenue up 7.2% and profit up 25.3% on a year earlier. ### Earlier - 21 Sep 2026: ex-date for a dividend of ₹0.50 a share. ## What dividend does Shivalik Rasayan pay? Shivalik Rasayan paid ₹0.50 a share in regular dividends in the 12 months to 18 November 2026 (1 payment), a yield of 0.17% at the ₹291.20 close on 18 November 2026. The last was a dividend of ₹0.50 a share, ex-date 21 September 2026. ### Shivalik Rasayan dividends since 1 April 2021 | Ex-date | Dividend per share | Type | Record date | | --- | --- | --- | --- | | 21 Sep 2026 | ₹0.50 | Dividend | same day | | 19 Sep 2025 | ₹0.50 | Dividend | 20 Sep 2025 | | 20 Sep 2024 | ₹0.50 | Dividend | n/a | | 22 Sep 2023 | ₹0.50 | Dividend | n/a | | 21 Sep 2022 | ₹0.50 | Dividend | n/a | Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 4 of 5 Of the last 5 financial years, years with an NSE dividend record Yes. Shivalik Rasayan Ltd paid out 6% of its profit as dividends in FY26, and it paid a dividend in 10 of its last 12 reported years. (From the NSE corporate-actions record, read 18 November 2026.) ## What to watch in Shivalik Rasayan's next results? When Shivalik Rasayan reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Revenue against the same quarter a year earlier. - Revenue against the same quarter a year earlier. In the Sep 2026 quarter, revenue was +7.2% on a year earlier, and the last four quarters averaged +14.9%. - Whether the operating margin stays near 14.7%. It is 1.9 percentage points higher than four quarters earlier. - Net profit against the same quarter a year earlier. In the Sep 2026 quarter, profit was +25.3% on a year earlier. It has grown on a year earlier for 3 quarters in a row. - Whether cash from operations catches up with profit. Only −88% of the last 3 years' profit came in as cash from operations. ## Which stock lists is Shivalik Rasayan on? Shivalik Rasayan is not on any of our India lists this week. ## Is Shivalik Rasayan profitable? Shivalik Rasayan Ltd earned ₹5.4 Cr of net profit in the Sep 2026 quarter, +25.3% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹18.0 Cr. Over 10 years profit has grown 19.6% a year on average. The same quarter a year earlier earned ₹4.3 Cr. The Sep 2026 quarter's profit is 5.4% of that quarter's revenue. For the full year, FY26 profit was ₹18.0 Cr (−18.2% on the year before). Why profit moved: revenue changed +7.2% on a year earlier and the margin moved +1.9 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +19.0% and revenue +14.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Shivalik Rasayan make, and is it growing? Shivalik Rasayan Ltd reported ₹101 Cr of revenue in the Sep 2026 quarter, +7.2% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 10 years it has grown 12.8% a year on average. The last full year, FY26, came in at ₹368 Cr. The last four reported quarters add to ₹382 Cr. FY26 revenue was ₹368 Cr, +17.9% on the year before. Recent pace: the last four quarters grew +14.9% on average, against 12.8% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +13.0%, against +13.1% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +7.7%, against +9.7% a year (stabilising). ## How much of every ₹100 of sales does Shivalik Rasayan keep? Shivalik Rasayan Ltd's operating margin was 14.7% in the Sep 2026 quarter, 1.9 percentage points higher than the same quarter a year ago. Across 12 years it has been between 7.3% and 21.9%. The latest quarter is within that range. Why the margin moved: operating margin changed +1.9 percentage points on the year while gross margin changed +0.4 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Shivalik Rasayan's profit turning into cash? Over the last 3 years Shivalik Rasayan Ltd's operations used more cash than they brought in, so cash conversion was −88%, a gap worth watching. In FY26 its operations used ₹34.0 Cr of cash, against ₹18.0 Cr of profit. After ₹17.0 Cr of spending on assets, free cash was −₹51.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why −88% of profit came in as cash: the cash cycle got 235 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 235 days longer. The next section looks at where the cash is stuck. ## Where does Shivalik Rasayan's cash go? Shivalik Rasayan Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 244 days in FY26, up from 9 days in FY21. It spent ₹108 Cr on assets over the last 3 years. Customers take 114 days to pay, and stock sits for 285 days on average. At FY26 sales of ₹368 Cr, each day of that cycle ties up about ₹1.0 Cr, so roughly ₹246 Cr is tied up in the business at any time. FY26: customers took 114 days to pay and stock sat for 285 days, about 9.4 months of sales sitting as stock, for a full cycle of 244 days, longer than FY21's 9. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 285 days. Customers pay about 114 days after that. Suppliers are paid at 155 days. Together that makes the 244-day cycle. Spending on assets: ₹108 Cr over the last 3 years, against ₹47.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Shivalik Rasayan's P/E ratio, and how does it compare with its own history? Shivalik Rasayan Ltd's P/E is 32.2×, near the low end of its own history: it has been lower only 32% of the time. Its usual P/E (the middle reading) is 41.0×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹9.05. Why the multiple is where it is: over the past year earnings per share moved −25.8% while the price moved −28.1%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −20.0% a year; about −12.2% a year came from earnings growth and about −7.8 percentage points from the multiple (the market paying less); over 10 years the price moved +12.1% a year; about −1.7% a year came from earnings growth and about +13.8 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. A quarterly PEG curve, which only the second data source has, is not shown on this page: its two data sources disagree by up to 31% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Is the Shivalik Rasayan business getting better or worse? Shivalik Rasayan Ltd's business is giving mixed signals. Growth has been steadily positive, but ROCE at 5.0% (four quarters to FY26) is below the 15% level needed to call it steady growth. This is based on 9 quarters of 4 measures, with some gaps. Why it matters: when the lines disagree, each line above matters more than any single label. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Shivalik Rasayan earn on its capital? Shivalik Rasayan Ltd earned a ROCE of 5% in FY26. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 4.9% net margin and 0.45× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 4.9% net margin × 0.45× asset turnover × 1.37× leverage (assets divided by equity) ≈ 3.0% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 31% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Does Shivalik Rasayan have too much debt? Shivalik Rasayan Ltd had ₹123 Cr of borrowings against ₹599 Cr of equity in FY26, so its debt is 0.21× its equity. Its operating profit is 4 times its interest bill. Over 5 years borrowings went from ₹29.0 Cr to ₹123 Cr. Over the last 3 of those years it spent ₹108 Cr on assets. Part of the spending on assets is being paid for with borrowed money. The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 31% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## What is the Shivalik Rasayan shareholding pattern? Foreign institutions cut their stake in Shivalik Rasayan Ltd by 2.6 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 0.7% of the company. Promoters moved −1.4 points over the same period, to 46.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −2.6 points over 8 quarters, to 0.7%; Promoters: −1.4 points over 8 quarters, to 46.5%; Domestic institutions: −0.9 points over 8 quarters, to 0.0%. Why the owners changed: foreign institutions drove it (−2.6 points), together with promoters (−1.4 points). They reduced their stake. ## How far is Shivalik Rasayan from balance-sheet trouble? For Shivalik Rasayan Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Shivalik Rasayan rank in its industry? 47.9 out of 100, rank 14 of 25 in Pesticides/Agrochemicals, with 67% of the evidence available. Shivalik Rasayan Ltd scores 47.9 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 14. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 19.7 + 9.5 + 7.7 + 11 = 47.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Shivalik Rasayan compared with? Shivalik Rasayan ranks 14 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 47.9 out of 100. 1. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) breaking out · Most evidence points up · 87% evidence 76.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.3/35 · Revenue 31.8% · Profit 38.7% · Operating margin change 3 points · 95% evidence Capital efficiency 21.3/25 · ROCE 22.8% (year to Mar 2026) · Operating margin 19.7% · 95% evidence Valuation 5.4/20 · P/E 55.2× · PEG n/a · 50% evidence Relative strength 18.6/20 · Strength vs its industry (price vs its 52-week average, weekly) 44.3% · Strength vs NIFTY 500 (same reading) 21.3% · 1 year 177.2% · 100% evidence · 4 of 12 weeks ahead Exact sum: 31.3 + 21.3 + 5.4 + 18.6 = 76.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Sharda Cropchem Ltd](https://www.sectoralpha.in/stocks/sharda-cropchem-ltd) SHARDACROP · basing · Most evidence points up · 100% evidence 66.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.2/35 · Revenue 17.3% · Profit 42.5% · Operating margin change 2 points · 100% evidence Capital efficiency 19.6/25 · ROCE 30.2% (year to Mar 2026) · Operating margin 15.6% · 100% evidence Valuation 11.5/20 · P/E 9.8× · PEG 2.26 · 100% evidence Relative strength 7.6/20 · Strength vs its industry (price vs its 52-week average, weekly) -5.2% · Strength vs NIFTY 500 (same reading) -21.1% · 1 year -12.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.2 + 19.6 + 11.5 + 7.6 = 66.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Jubilant Ingrevia Ltd](https://www.sectoralpha.in/stocks/jubilant-ingrevia-ltd) JUBLINGREA · quiet · Most evidence points up · 93% evidence 65.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.4/35 · Revenue 15.4% · Profit 21.9% · Operating margin change 3 points · 100% evidence Capital efficiency 13.8/25 · ROCE 11.4% (year to Mar 2026) · Operating margin 15.2% · 100% evidence Valuation 12.9/20 · P/E 26.7× · PEG 1.16 · 65% evidence Relative strength 11.2/20 · Strength vs its industry (price vs its 52-week average, weekly) 3.8% · Strength vs NIFTY 500 (same reading) -13.5% · 1 year -18.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 27.4 + 13.8 + 12.9 + 11.2 = 65.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Bayer CropScience Ltd](https://www.sectoralpha.in/stocks/bayer-cropscience-ltd) BAYERCROP · quiet · Evidence leans up · 85% evidence 63.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.5/35 · Revenue -5% · Profit 22.5% · Operating margin change 4 points · 100% evidence Capital efficiency 19.3/25 · ROCE 29.1% (year to Mar 2026) · Operating margin 17.4% · 100% evidence Valuation 10.6/20 · P/E 20.2× · PEG 2.21 · 100% evidence Relative strength 8.6/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -22.1% · 1 year -26.2% · 25% evidence · 0 of 12 weeks ahead Exact sum: 24.5 + 19.3 + 10.6 + 8.6 = 63 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) DHANUKA · quiet · Evidence leans up · 100% evidence 54.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.0/35 · Revenue 0% · Profit 0.7% · Operating margin change 0 points · 100% evidence Capital efficiency 19.8/25 · ROCE 25.9% (year to Mar 2026) · Operating margin 23.3% · 100% evidence Valuation 11.4/20 · P/E 14.8× · PEG 2.07 · 100% evidence Relative strength 13.5/20 · Strength vs its industry (price vs its 52-week average, weekly) 0.8% · Strength vs NIFTY 500 (same reading) -16.1% · 1 year -23.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 10 + 19.8 + 11.4 + 13.5 = 54.7 · What this means: Relative strength against the index is -16.1%, and revenue and profit growth are weak. 6. [Advance Agrolife Ltd](https://www.sectoralpha.in/stocks/advance-agrolife-ltd) ADVANCE · losing its lead · Evidence leans up · 68% evidence 54.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.0/35 · Revenue 49.4% · Profit 55.2% · Operating margin change -4 points · 100% evidence Capital efficiency 13.7/25 · ROCE 19.6% (year to Mar 2026) · Operating margin 7.7% · 100% evidence Valuation 10.1/20 · P/E 17.4× · PEG n/a · 15% evidence Relative strength 11.9/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 2.3% · 1 year -8.5% · 25% evidence · 10 of 12 weeks ahead Exact sum: 19 + 13.7 + 10.1 + 11.9 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) PUNJABCHEM · quiet · Evidence leans up · 75% evidence 53.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.6/35 · Revenue 14% · Profit 13.2% · Operating margin change -1 points · 100% evidence Capital efficiency 13.2/25 · ROCE 18.6% (year to Mar 2026) · Operating margin 9.2% · 100% evidence Valuation 11.0/20 · P/E 17.9× · PEG n/a · 50% evidence Relative strength 9.2/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -19% · 1 year -34.1% · 25% evidence · 3 of 12 weeks ahead Exact sum: 19.6 + 13.2 + 11 + 9.2 = 53 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) DHARMAJ · quiet · Evidence leans up · 75% evidence 52.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.5/35 · Revenue 3.8% · Profit 14.3% · Operating margin change -2 points · 100% evidence Capital efficiency 14.7/25 · ROCE 16.8% (year to Mar 2026) · Operating margin 7.2% · 100% evidence Valuation 13.2/20 · P/E 15.1× · PEG n/a · 50% evidence Relative strength 10.0/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -9.7% · 1 year -0.9% · 25% evidence · 5 of 12 weeks ahead Exact sum: 14.5 + 14.7 + 13.2 + 10 = 52.4 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) BESTAGRO · quiet · Evidence leans up · 90% evidence 52.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.7/35 · Revenue -19.6% · Profit 100% · Operating margin change 10 points · 100% evidence Capital efficiency 10.0/25 · ROCE 5.2% (year to Mar 2026) · Operating margin 24.8% · 100% evidence Valuation 11.3/20 · P/E 10.8× · PEG n/a · 50% evidence Relative strength 6.0/20 · Strength vs its industry (price vs its 52-week average, weekly) -4.7% · Strength vs NIFTY 500 (same reading) -20.8% · 1 year -26.5% · 100% evidence · 7 of 12 weeks ahead Exact sum: 24.7 + 10 + 11.3 + 6 = 52 · What this means: Earnings are strong; relative strength in its sector is -4.7% and the one-year return is -26.5%. 10. [Meghmani Organics Ltd](https://www.sectoralpha.in/stocks/meghmani-organics-ltd) MOL · quiet · Evidence leans down · 68% evidence 49.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.9/35 · Revenue -5.2% · Profit 100% · Operating margin change 2 points · 100% evidence Capital efficiency 7.7/25 · ROCE 6.7% (year to Mar 2026) · Operating margin 10.9% · 100% evidence Valuation 10.4/20 · P/E 15.6× · PEG n/a · 15% evidence Relative strength 10.7/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -2.3% · 1 year -23.9% · 25% evidence · 8 of 12 weeks ahead Exact sum: 20.9 + 7.7 + 10.4 + 10.7 = 49.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Excel Industries Ltd](https://www.sectoralpha.in/stocks/excel-industries-ltd) EXCELINDUS · losing its lead · Evidence leans down · 68% evidence 49.0 out of 100 Growth Capital Valuation Relative 12. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) UPL · basing · Evidence leans down · 82% evidence 48.9 out of 100 Growth Capital Valuation Relative 13. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) RALLIS · quiet · Evidence leans down · 85% evidence 47.9 out of 100 Growth Capital Valuation Relative 14. Shivalik Rasayan Ltd this page SHIVALIK · turning · Evidence leans down · 67% evidence 47.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.7/35 · Revenue 13% · Profit 7.7% · Operating margin change 1.9 points · 95% evidence Capital efficiency 9.5/25 · ROCE 4.8% (year to Mar 2026) · Operating margin 14.8% · 76% evidence Valuation 7.7/20 · P/E 32.2× · PEG n/a · 50% evidence Relative strength 11.0/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) -1% · 1 year -28.1% · 25% evidence · 1 of 1 week ahead Exact sum: 19.7 + 9.5 + 7.7 + 11 = 47.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 15. [Bhagiradha Chemicals & Industries Ltd](https://www.sectoralpha.in/stocks/bhagiradha-chemicals-industries-ltd) BHAGCHEM · quiet · Evidence leans down · 83% evidence 47.7 out of 100 Growth Capital Valuation Relative 16. [Epigral Ltd](https://www.sectoralpha.in/stocks/epigral-ltd) EPIGRAL · quiet · Evidence leans down · 75% evidence 46.8 out of 100 Growth Capital Valuation Relative 17. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) IPL · quiet · Evidence leans down · 75% evidence 46.0 out of 100 Growth Capital Valuation Relative 18. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) SUMICHEM · quiet · Evidence leans down · 85% evidence 43.7 out of 100 Growth Capital Valuation Relative 19. [Insecticides India Ltd](https://www.sectoralpha.in/stocks/insecticides-india-ltd) INSECTICID · quiet · Evidence leans down · 90% evidence 42.8 out of 100 Growth Capital Valuation Relative 20. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) BHARATRAS · basing · Evidence leans down · 90% evidence 42.4 out of 100 Growth Capital Valuation Relative 21. [GSP Crop Science Ltd](https://www.sectoralpha.in/stocks/gsp-crop-science-ltd) GSPCROP · quiet · Evidence leans down · 63% evidence 39.8 out of 100 Growth Capital Valuation Relative 22. [P I Industries Ltd](https://www.sectoralpha.in/stocks/p-i-industries-ltd) PIIND · quiet · Most evidence points down · 75% evidence 34.5 out of 100 Growth Capital Valuation Relative 23. [NACL Industries Ltd](https://www.sectoralpha.in/stocks/nacl-industries-ltd) NACLIND · basing · Most evidence points down · 90% evidence 32.9 out of 100 Growth Capital Valuation Relative 24. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) HERANBA · quiet · Most evidence points down · 71% evidence 31.9 out of 100 Growth Capital Valuation Relative 25. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ASTEC · quiet · Most evidence points down · 71% evidence 31.3 out of 100 Growth Capital Valuation Relative Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Pesticides/Agrochemicals](https://www.sectoralpha.in/sectors/pesticides-agrochemicals), all 25 compared on one page. ## Which companies are close to Shivalik Rasayan in size? Shivalik Rasayan is the 25th largest of 25 Pesticides/Agrochemicals companies on Sector Alpha by market value (at the 18 November 2026 close). Just above it: Astec Lifesciences, Punjab Chemicals & Crop Protection, Dharmaj Crop Guard, Advance Agrolife, Heranba Industries and Best Agrolife. It is the smallest. ### Pesticides/Agrochemicals companies close in size 1. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ₹1,222 crore 2. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) ₹1,080 crore 3. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) ₹847 crore 4. [Advance Agrolife Ltd](https://www.sectoralpha.in/stocks/advance-agrolife-ltd) ₹777 crore 5. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) ₹583 crore 6. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) ₹521 crore 7. Shivalik Rasayan Ltd ₹467 crore [All 25 Pesticides/Agrochemicals companies, largest first](https://www.sectoralpha.in/sectors/pesticides-agrochemicals#all-companies) ### Companies close in size in other industries 1. [Oswal Agro Mills Ltd](https://www.sectoralpha.in/stocks/oswal-agro-mills-ltd) ₹468 crore · Trading 2. [Niyogin Fintech Ltd](https://www.sectoralpha.in/stocks/niyogin-fintech-ltd) ₹467 crore · Finance & Investments - Others 3. Shivalik Rasayan Ltd ₹467 crore 4. [Shish Industries Ltd](https://www.sectoralpha.in/stocks/shish-industries-ltd) ₹466 crore · Plastics - Sheets/Films 5. [Committed Cargo Care Ltd](https://www.sectoralpha.in/stocks/committed-cargo-care-ltd) ₹466 crore ## What else do people ask about Shivalik Rasayan? ### What were Shivalik Rasayan's latest quarterly results? Shivalik Rasayan Ltd reported revenue of ₹101 Cr and net profit of ₹5.4 Cr for the Sep 2026 quarter. Revenue rose 7.2% and profit rose 25.3% compared with a year earlier. Earnings per share were ₹2.30. The operating margin was 14.7%, 1.9 percentage points higher than a year earlier (as of 18 November 2026). ### What is Shivalik Rasayan's market cap? Shivalik Rasayan Ltd's market capitalisation is ₹467 Cr at a share price of ₹291.20. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026). ### How is Shivalik Rasayan performing? Shivalik Rasayan Ltd's share price is in an uptrend that has just slipped below its 200-day average. In its latest quarter, revenue rose 7.2% and profit rose 25.3% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 2 weeks running (as of 18 November 2026). ### Will Shivalik Rasayan's share price go up? This page does not forecast Shivalik Rasayan Ltd's share price. What it shows instead: the share price is ₹291.20, and it has been rising for 7 weeks. Its P/E of 32.2× is higher than 32% of its own last 11 years (as of 18 November 2026). ### Who owns Shivalik Rasayan? Promoters own 46.5% of Shivalik Rasayan Ltd, foreign institutions 0.7%, domestic institutions 0.0% and the public 52.7% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 2.6 percentage points over 8 quarters (as of 18 November 2026). ### Where is Shivalik Rasayan in its business cycle? Shivalik Rasayan Ltd's FY26 operating margin was 12.8%, against a 12-year range of 7.3% to 21.9%. The latest quarter was 14.7%, the middle of its own range, neither a peak nor a low. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026). ### What could break the Shivalik Rasayan story? The main question: profits are rising, but only −88% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026). ### Is Shivalik Rasayan a stock worth studying right now? What the numbers show: Shivalik Rasayan Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 32% of past readings. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026). This is research, not advice. We’re not SEBI-registered.